FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4986411000001108: Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23551901000001110 Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
75153901000001119 Lithium succinate 8% / Zinc sulfate 0.05% ointment 20 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Is pack of Lithium succinate 8% / Zinc sulphate 0.05% ointment false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has active ingredient Zinc sulfate false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has active ingredient Lithium succinate false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has VMP Lithium succinate 8% / Zinc sulphate 0.05% ointment true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has specific active ingredient Lithium succinate true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has specific active ingredient Zinc sulfate true Inferred relationship Existential restriction modifier
Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Efalith ointment (Scotia Pharmaceuticals Ltd) 20 gram Is a True Lithium succinate 8% / Zinc sulphate 0.05% ointment 20 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start